Dimitri Panayotopoulos - British Amer Senior Non-Executive Independent Director
| BTI Stock | USD 37.94 0.23 0.61% |
Director
Mr. Dimitri E. Panayotopoulos is NonExecutive Independent Director of British American Tobacco PLC., since February 2015. Dimitri has extensive general management and international sales and brand building expertise. He was Vice Chairman and Adviser to the Chairman and CEO of Procter Gamble, where he started his career in 1977. During his time at PG, Dimitri led on significant breakthrough innovations and continued to focus on this, speedtomarket and scale across all of PGs businesses while Vice Chairman of all the Global Business Units. since 2020.
| Age | 69 |
| Tenure | 4 years |
| Address | Globe House, London, United Kingdom, WC2R 2PG |
| Phone | 44 20 7845 1000 |
| Web | https://www.bat.com |
British Amer Management Efficiency
The company has Return on Asset of 0.0516 % which means that on every $100 spent on assets, it made $0.0516 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.215) %, meaning that it generated no profit with money invested by stockholders. British Amer's management efficiency ratios could be used to measure how well British Amer manages its routine affairs as well as how well it operates its assets and liabilities. The British Amer's current Return On Tangible Assets is estimated to increase to -0.59. The British Amer's current Return On Capital Employed is estimated to increase to -0.15. As of now, British Amer's Other Current Assets are increasing as compared to previous years. The British Amer's current Intangible Assets is estimated to increase to about 57.2 B, while Total Current Assets are projected to decrease to under 9.3 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Assia GrazioliVenier | Turning Point Brands | 40 | |
| John Casteen | Altria Group | 77 | |
| Stephen Usher | Turning Point Brands | 54 | |
| Robert Sledd | Universal | 67 | |
| Eddie Moore | Universal | 71 | |
| Lennart Freeman | Universal | 69 | |
| Peter Durman | Imperial Brands PLC | N/A | |
| Mark Newman | Altria Group | 57 | |
| George Munoz | Altria Group | 70 | |
| John Charnovich | Turning Point Brands | 63 | |
| H Diao | Turning Point Brands | 63 | |
| Dessislava Temperley | Philip Morris International | 48 | |
| Muneaki Fujimoto | Japan Tobacco ADR | N/A | |
| Diana Cantor | Universal | 62 | |
| Ashley Frushone | Turning Point Brands | 46 | |
| Werner Geissler | Philip Morris International | 67 | |
| Robert Polet | Philip Morris International | 65 | |
| Thomas Johnson | Universal | 70 | |
| Jun Makihara | Philip Morris International | 63 | |
| Gregory Baxter | Turning Point Brands | 67 | |
| Peter Durman | Imperial Brands PLC | N/A | |
Management Performance
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.0516 |
British American Tobacco Leadership Team
Elected by the shareholders, the British Amer's board of directors comprises two types of representatives: British Amer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of British. The board's role is to monitor British Amer's management team and ensure that shareholders' interests are well served. British Amer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, British Amer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Waterfield, Member Board | ||
| Lance Mucalo, Head Products | ||
| David OReilly, Director - Research and Science | ||
| Syed Iqbal, Dire Dire | ||
| Dimitri Panayotopoulos, Senior Non-Executive Independent Director | ||
| Paul McCrory, Company Secretary | ||
| Jack Bowles, Regional Director of Asia Pacific and Member of the Management Board | ||
| Susan Farr, Non-Executive Independent Director | ||
| Guy Meldrum, President and Chief Executive Officer of Reynolds American Inc | ||
| Javed Iqbal, Director - Digital and Information | ||
| Craig Harris, Head MA | ||
| Luc Jobin, Non-Executive Independent Director | ||
| J Thomas, Non-Executive Independent Director | ||
| Michael Dijanosic, Regional Director - Asia Pacific and Middle East | ||
| Hae Kim, Director - Talent, Culture and Inclusion | ||
| Marina Bellini, Director - Digital and Information | ||
| Marion Helmes, Non-Executive Independent Director | ||
| Ricardo Oberlander, President and Chief Executive Officer of Reynolds American Inc. | ||
| Jeremy Fowden, Non-Executive Independent Director | ||
| James Barrett, Director Board | ||
| Tadeu Marroco, Finance Director, Director - Group Transformation, Director | ||
| Krishnan Anand, Non-Executive Independent Director | ||
| Victoria Buxton, Head Relations | ||
| Savio Kwan, Non-Executive Independent Director | ||
| Holly Koeppel, Non-Executive Independent Director | ||
| Mihovil Dijanosic, Middle AsiaPacific | ||
| Jerome Abelman, Director, Legal & External Affairs and General Counsel | ||
| Soraya Benchikh, Member CFO | ||
| Luciano Comin, Regional Director - Americas and Sub Saharan Africa (AMSSA) | ||
| Paul Lageweg, Director - New Categories | ||
| Kingsley Wheaton, Chief Marketing Officer, Regional Director - Americas and Sub Saharan Africa (AMSSA) | ||
| Darrell Thomas, Non-Executive Independent Director | ||
| Zafar Khan, Group Head - New Categories Operations | ||
| Alan Davy, Group Operations Director | ||
| Karen Guerra, Non-Executive Independent Director | ||
| Richard Burrows, Non-Executive Chairman of the Board | ||
| Johan Vandermeulen, Regional Director - Europe and North Africa | ||
| FFPM MBA, Chief Officer |
British Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is British Amer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.21 | ||||
| Return On Asset | 0.0516 | ||||
| Profit Margin | (0.53) % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 124.73 B | ||||
| Shares Outstanding | 2.21 B | ||||
| Shares Owned By Insiders | 0.27 % | ||||
| Shares Owned By Institutions | 8.32 % | ||||
| Number Of Shares Shorted | 6.44 M | ||||
| Price To Earning | 10.41 X |
Currently Active Assets on Macroaxis
When determining whether British American Tobacco offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of British Amer's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of British American Tobacco Stock. Outlined below are crucial reports that will aid in making a well-informed decision on British American Tobacco Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in British American Tobacco. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Tobacco space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of British Amer. If investors know British will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about British Amer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.138 | Dividend Share 2.332 | Earnings Share (7.93) | Revenue Per Share 2.3524 | Quarterly Revenue Growth (0.08) |
The market value of British American Tobacco is measured differently than its book value, which is the value of British that is recorded on the company's balance sheet. Investors also form their own opinion of British Amer's value that differs from its market value or its book value, called intrinsic value, which is British Amer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because British Amer's market value can be influenced by many factors that don't directly affect British Amer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between British Amer's value and its price as these two are different measures arrived at by different means. Investors typically determine if British Amer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, British Amer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.